Direct versus indirect comparisons: a summary of the evidence

International Journal of Technology Assessment in Health Care
Gerald Gartlehner, Charity G Moore

Abstract

The aim of this study was to provide a comprehensive summary and interpretation of the current evidence on the use and validity of statistical methods to conduct indirect comparisons of treatment effects. A narrative review was conducted. Well-conducted methodological studies provide good evidence that adjusted indirect comparisons can lead to results similar to those from direct comparisons. The internal validity of several statistical methods to conduct indirect comparisons, therefore, has been established. Meta-regression, logistic regression, or adjusted indirect comparisons should be the methods of first choice. Unadjusted indirect comparisons are always unacceptable. Deciding whether to combine direct and indirect evidence will be a matter of informed judgment based on the similarities and dissimilarities of populations and interventions. Unverifiable assumptions with respect to the similarity of compared studies and low power are serious limitations of indirect comparisons. In the absence of sufficient head-to-head evidence, adjusted indirect comparisons can be viewed as additional analytical tools to determine the comparative efficacy and effectiveness of competing interventions. Researchers who use indirect comparisons...Continue Reading

References

Jan 1, 1996·Progress in Neuro-psychopharmacology & Biological Psychiatry·M DierickA Martin
Oct 27, 1997·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·L A Cunningham
Nov 26, 1999·European Psychiatry : the Journal of the Association of European Psychiatrists·D SechterP Boyer
Apr 29, 2000·Annals of Internal Medicine·W L GreeneA R Feinstein
Sep 12, 2000·The Journal of Clinical Psychiatry·P A NewhouseC M Clary
Dec 26, 2001·JAMA : the Journal of the American Medical Association·K KroenkeM Weinberger
Apr 10, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN Hypericum Depression Trial Study GroupRichard H Weisler
Jul 24, 2002·The International Journal of Neuropsychopharmacology·Andre De NayerAnnick Mignon
Sep 5, 2002·Statistics in Medicine·Thomas Lumley
Nov 14, 2002·BMC Medical Research Methodology·Stuart G Baker, Barnett S Kramer
Jul 2, 2003·The American Journal of Psychiatry·Lon S SchneiderUNKNOWN Sertraline Elderly Depression Study Group
Sep 28, 2004·Statistics in Medicine·G Lu, A E Ades
Jul 15, 2005·Health Technology Assessment : HTA·A M GlennyUNKNOWN International Stroke Trial Collaborative Group
Sep 17, 2005·Journal of Psychiatric Research·Charles B NemeroffUNKNOWN EPIC 014 Study Group
Oct 15, 2005·BMJ : British Medical Journal·Deborah M CaldwellJ P T Higgins
Mar 9, 2006·JAMA : the Journal of the American Medical Association·Peter C Gøtzsche
Apr 4, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Alan Schatzberg, Steven Roose
Oct 31, 2006·Lancet·John P A Ioannidis
Jan 1, 1997·European Psychiatry : the Journal of the Association of European Psychiatrists·J OlieE Katz

❮ Previous
Next ❯

Citations

Sep 14, 2012·BMC Medical Research Methodology·Marian S McDonaghMark Helfand
Sep 10, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Olalekan A Uthman, Ismail Yahaya
Jan 13, 2016·Research Synthesis Methods·Orestis EfthimiouUNKNOWN GetReal Methods Review Group
Dec 7, 2010·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Stefan Lange, Stefanie Thomas
Aug 13, 2009·Thérapie·Bruno FalissardFrançois Meyer
Nov 5, 2015·Research Synthesis Methods·Hwanhee HongBradley P Carlin
Jul 24, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Atbin DjamshidianBruno B Averbeck
Dec 1, 2013·Research Synthesis Methods·Sarah DoneganCatrin Tudur Smith
Sep 25, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Sarah KleijnenWim G Goettsch
Sep 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Roman CascianoLou Garrison
Aug 23, 2012·Circulation. Cardiovascular Quality and Outcomes·William L Baker, Olivia J Phung
Feb 27, 2010·Nature Reviews. Drug Discovery·Hans-Georg EichlerSteven Pearson
Sep 23, 2010·Scandinavian Journal of Rheumatology·J C F van LuijnH G M Leufkens
Jun 22, 2012·Expert Review of Anticancer Therapy·Jennifer G GaultneyCarin A Uyl-de Groot
Nov 4, 2011·Clinical Trials : Journal of the Society for Clinical Trials·Jesse A Berlin, M Soledad Cepeda
Dec 2, 2010·Sleep·Ingeborg M van GeijlswijkMarcel G Smits

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.